000140841 001__ 140841
000140841 005__ 20230915100838.0
000140841 0247_ $$2doi$$a10.1007/s00103-019-02985-z
000140841 0247_ $$2pmid$$apmid:31297549
000140841 0247_ $$2ISSN$$a1436-9990
000140841 0247_ $$2ISSN$$a1437-1588
000140841 0247_ $$2altmetric$$aaltmetric:66840263
000140841 037__ $$aDZNE-2020-07163
000140841 041__ $$ager
000140841 082__ $$a610
000140841 1001_ $$0P:(DE-2719)2810763$$aMichalowsky, Bernhard$$b0$$eFirst author
000140841 245__ $$a[The economic and social burden of dementia diseases in Germany-A meta-analysis].
000140841 260__ $$aHeidelberg$$bSpringer$$c2019
000140841 264_1 $$2Crossref$$3online$$bSpringer Science and Business Media LLC$$c2019-07-11
000140841 264_1 $$2Crossref$$3print$$bSpringer Science and Business Media LLC$$c2019-08-01
000140841 3367_ $$2DRIVER$$aarticle
000140841 3367_ $$2DataCite$$aOutput Types/Journal article
000140841 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1688391552_14566
000140841 3367_ $$2BibTeX$$aARTICLE
000140841 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000140841 3367_ $$00$$2EndNote$$aJournal Article
000140841 520__ $$aCurrently, there are 1.7 million people living with dementia (PwD) in Germany. This number is expected to double within the next decades. Estimates of the total societal economic burden of dementia are currently missing.The aim was to estimate the current and future total cost and excess cost of dementia from a public payer and societal perspective.Studies demonstrating the healthcare resource utilization of PwD in Germany were identified. Utilization data were aggregated using the sample size of different studies as a weight. Annual per capita costs of PwD and excess cost of dementia were calculated using standardized unit costs. Current and future costs were calculated based on published prevalence and population forecasts.PwD living at home had lower costs from a payer perspective compared to those who are institutionalized, but higher total societal cost due to the higher informal care time. The total cost for PwD from a payer perspective was 34 billion € in 2016. These costs could reach 90 billion € by 2060. The excess cost of dementia was 18 billion € in 2016 and is estimated to become 49 billion € by 2060 from a payer perspective, representing 54% of the total cost of PwD and up to 15% of the total costs associated with the elderly population. The total societal cost was 73 billion € in 2016 and is estimated to become 194 billion € by 2060. The excess cost of dementia was 54 billion € in 2016 and is estimated to become 145 billion € by 2060, representing 74% of the total societal cost of PwD and 36% of the total societal cost of the elderly.Dementia diseases represent a tremendous social and economic burden. Without a cure, supporting caregivers and implementing interventions that delay the functional and cognitive decline will be crucial to relieving the increasing costs.
000140841 536__ $$0G:(DE-HGF)POF3-344$$a344 - Clinical and Health Care Research (POF3-344)$$cPOF3-344$$fPOF III$$x0
000140841 542__ $$2Crossref$$i2019-07-11$$uhttps://creativecommons.org/licenses/by/4.0
000140841 588__ $$aDataset connected to CrossRef, PubMed,
000140841 650_2 $$2MeSH$$aAged
000140841 650_2 $$2MeSH$$aAged, 80 and over
000140841 650_2 $$2MeSH$$aAging
000140841 650_2 $$2MeSH$$aCaregivers: economics
000140841 650_2 $$2MeSH$$aCaregivers: statistics & numerical data
000140841 650_2 $$2MeSH$$aCost of Illness
000140841 650_2 $$2MeSH$$aDementia: economics
000140841 650_2 $$2MeSH$$aDementia: psychology
000140841 650_2 $$2MeSH$$aGermany
000140841 650_2 $$2MeSH$$aHealth Care Costs: statistics & numerical data
000140841 650_2 $$2MeSH$$aHumans
000140841 650_2 $$2MeSH$$aPatient Acceptance of Health Care
000140841 650_2 $$2MeSH$$aResource Allocation
000140841 7001_ $$0P:(DE-2719)9001134$$aRädke, Anika$$b1$$udzne
000140841 7001_ $$0P:(DE-2719)2000040$$aHoffmann, Wolfgang$$b2$$eLast author
000140841 77318 $$2Crossref$$3journal-article$$a10.1007/s00103-019-02985-z$$b : Springer Science and Business Media LLC, 2019-07-11$$n8$$p981-992$$tBundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz$$v62$$x1436-9990$$y2019
000140841 773__ $$0PERI:(DE-600)1470303-8$$a10.1007/s00103-019-02985-z$$gVol. 62, no. 8, p. 981 - 992$$n8$$p981-992$$q62:8<981 - 992$$tBundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz$$v62$$x1436-9990$$y2019
000140841 8564_ $$uhttps://pub.dzne.de/record/140841/files/DZNE-2020-07163.pdf$$yOpenAccess
000140841 8564_ $$uhttps://pub.dzne.de/record/140841/files/DZNE-2020-07163.pdf?subformat=pdfa$$xpdfa$$yOpenAccess
000140841 909CO $$ooai:pub.dzne.de:140841$$pdnbdelivery$$pdriver$$pVDB$$popen_access$$popenaire
000140841 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2810763$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b0$$kDZNE
000140841 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)9001134$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b1$$kDZNE
000140841 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2000040$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b2$$kDZNE
000140841 9131_ $$0G:(DE-HGF)POF3-344$$1G:(DE-HGF)POF3-340$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lErkrankungen des Nervensystems$$vClinical and Health Care Research$$x0
000140841 9141_ $$y2019
000140841 915__ $$0LIC:(DE-HGF)CCBY4$$2HGFVOC$$aCreative Commons Attribution CC BY 4.0
000140841 915__ $$0StatID:(DE-HGF)0510$$2StatID$$aOpenAccess
000140841 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2022-11-16
000140841 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2022-11-16
000140841 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2022-11-16
000140841 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2022-11-16
000140841 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bBUNDESGESUNDHEITSBLA : 2021$$d2022-11-16
000140841 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5$$d2022-11-16
000140841 9201_ $$0I:(DE-2719)5000001$$kAG Grabe$$lBiomarkers of Dementia in the General Population$$x0
000140841 9201_ $$0I:(DE-2719)1510600$$kAG Hoffmann$$lTranslational Health Care Research$$x1
000140841 980__ $$ajournal
000140841 980__ $$aVDB
000140841 980__ $$aI:(DE-2719)5000001
000140841 980__ $$aI:(DE-2719)1510600
000140841 980__ $$aUNRESTRICTED
000140841 9801_ $$aFullTexts
000140841 999C5 $$2Crossref$$oDeutsche Alzheimer Gesellschaft e. V. Die Häufigkeit von Demenzerkrankungen 2016$$tDie Häufigkeit von Demenzerkrankungen$$y2016
000140841 999C5 $$2Crossref$$oDeutsche Alzheimer Gesellschaft e. V. Die Epidemiologie der Demenz. Das Wichtigste 2015$$tDie Epidemiologie der Demenz. Das Wichtigste$$y2015
000140841 999C5 $$2Crossref$$9-- missing cx lookup --$$a10.3233/JAD-150935$$o10.3233/JAD-150935
000140841 999C5 $$2Crossref$$oJR Thyrian 2011$$y2011
000140841 999C5 $$2Crossref$$9-- missing cx lookup --$$a10.1007/s10198-017-0869-7$$o10.1007/s10198-017-0869-7
000140841 999C5 $$2Crossref$$9-- missing cx lookup --$$a10.1111/inr.12194$$o10.1111/inr.12194
000140841 999C5 $$2Crossref$$oStatistisches Bundesamt Gesundheits, Krankheitskosten 2002, 2004, 2006, 2008 und 2015 2016$$tGesundheits, Krankheitskosten 2002, 2004, 2006, 2008 und 2015$$y2016
000140841 999C5 $$2Crossref$$9-- missing cx lookup --$$a10.3233/JAD-140354$$o10.3233/JAD-140354
000140841 999C5 $$2Crossref$$9-- missing cx lookup --$$a10.2147/JMDH.S80560$$o10.2147/JMDH.S80560
000140841 999C5 $$2Crossref$$9-- missing cx lookup --$$a10.3233/JAD-2011-110539$$o10.3233/JAD-2011-110539
000140841 999C5 $$2Crossref$$9-- missing cx lookup --$$a10.1186/1471-2318-10-24$$o10.1186/1471-2318-10-24
000140841 999C5 $$2Crossref$$9-- missing cx lookup --$$a10.1007/s12603-010-0311-7$$o10.1007/s12603-010-0311-7
000140841 999C5 $$2Crossref$$9-- missing cx lookup --$$a10.1111/j.1600-0447.2011.01741.x$$o10.1111/j.1600-0447.2011.01741.x
000140841 999C5 $$2Crossref$$9-- missing cx lookup --$$a10.1016/j.jamda.2017.10.013$$o10.1016/j.jamda.2017.10.013
000140841 999C5 $$2Crossref$$9-- missing cx lookup --$$a10.3233/JAD-122392$$o10.3233/JAD-122392
000140841 999C5 $$2Crossref$$9-- missing cx lookup --$$a10.3233/JAD-180275$$o10.3233/JAD-180275
000140841 999C5 $$2Crossref$$9-- missing cx lookup --$$a10.1016/j.jamda.2013.10.003$$o10.1016/j.jamda.2013.10.003
000140841 999C5 $$2Crossref$$9-- missing cx lookup --$$a10.1016/0022-3956(75)90026-6$$o10.1016/0022-3956(75)90026-6
000140841 999C5 $$2Crossref$$9-- missing cx lookup --$$a10.1186/2046-4053-4-1$$o10.1186/2046-4053-4-1
000140841 999C5 $$2Crossref$$oJO Bock 2015$$y2015
000140841 999C5 $$2Crossref$$oStatistisches Bundesamt Verdienste und Arbeitskosten – Arbeitnehmerverdienste 2015$$tVerdienste und Arbeitskosten – Arbeitnehmerverdienste$$y2015
000140841 999C5 $$2Crossref$$9-- missing cx lookup --$$a10.1007/s40273-016-0468-y$$o10.1007/s40273-016-0468-y
000140841 999C5 $$2Crossref$$oStatistisches Bundesamt Bevölkerung Deutschlands bis 2060. 13. koordinierte Bevölkerungsvorausberechnung 2013$$tBevölkerung Deutschlands bis 2060. 13. koordinierte Bevölkerungsvorausberechnung$$y2013
000140841 999C5 $$2Crossref$$9-- missing cx lookup --$$a10.1159/000310350$$o10.1159/000310350
000140841 999C5 $$2Crossref$$9-- missing cx lookup --$$a10.3111/13696998.2015.1014090$$o10.3111/13696998.2015.1014090
000140841 999C5 $$2Crossref$$9-- missing cx lookup --$$a10.1016/j.jval.2011.04.005$$o10.1016/j.jval.2011.04.005
000140841 999C5 $$2Crossref$$9-- missing cx lookup --$$a10.1186/1472-6963-13-2$$o10.1186/1472-6963-13-2
000140841 999C5 $$2Crossref$$9-- missing cx lookup --$$a10.5414/CP202729$$o10.5414/CP202729
000140841 999C5 $$2Crossref$$9-- missing cx lookup --$$a10.1001/jamaneurol.2017.1964$$o10.1001/jamaneurol.2017.1964
000140841 999C5 $$2Crossref$$oThe Economist Assessing the socioeconomic Impact of Alzheimer’s Diseases in Western Europe and Canada 2017$$tAssessing the socioeconomic Impact of Alzheimer’s Diseases in Western Europe and Canada$$y2017
000140841 999C5 $$2Crossref$$oWIdO (Wissenschaftliches Institut der AOK) GKV-Arzneimittelindex 2016$$tGKV-Arzneimittelindex$$y2016
000140841 999C5 $$2Crossref$$oKassenärztliche Vereinigung Einheitlicher Bewertungsmaßstab (EBM), Ausgabe mit Euro-Beträgen auf der Grundlage des bundeseinheitlichen Orientierungspunktwertes 2011$$tEinheitlicher Bewertungsmaßstab (EBM), Ausgabe mit Euro-Beträgen auf der Grundlage des bundeseinheitlichen Orientierungspunktwertes$$y2011